Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Today UK News Reporter: Debbie Casey
Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Healthcare Newsdesk brings the latest UK Healthcare News to you by NTS.Healthcare Newsdesk
Client company Optellum announces strategic collaboration with Johnson & Johnson
The Oxford Trust is an independent charitable trust that was established in 1985 by Oxford entrepreneurs Sir Martin and Lady Audrey Wood, founders of Oxford Instruments.The Oxford Trust
Optellum collaborating with Johnson & Johnson
The National Consortium of Intelligent Medical Imaging (NCIMI) is revolutionising healthcare through Artificial Intelligence (AI). We are a partnership between NHS trusts, companies, universities, charities and patient groups coordinated by…
Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, applying AI to transform early lung cancer treatment
IQ Capital (who invested in Optellum in 2019) is a deep-tech early stage VC investing in UK companies capable of dominating global markets.IQ Capital
Oxford spin out partners with J&J to transform lung cancer treatment
University of Oxford Medical sciences division
Lung health startup partners with Johnson & Johnson’s lung cancer initiative
The Clinical Services Journal is the must-read publication for healthcare professionals in across the sector. Clinical Services Journal
Lung health startup partners with Johnson & Johnson’s lung cancer initiative
Health Tech World is for everyone with a professional interest in health technology. It unites academics, researchers, governments and businesses of all sizes around the world working to progress the…